Read the full press release below:
------------------------------------------------------------------------------------------------------------
WILMINGTON, N.C., (November 29, 2012) -
Pharmaceutical Product Development, LLC (PPD)
today announced it has been recognized by Scrip Intelligence with its
2012 award for Best Technological Development in Clinical Trials for deploying
cutting-edge solutions advancing clinical research.
PPD received the honor at the annual Scrip Awards ceremony Nov. 28
in London, marking the second consecutive year PPD won for best technology
after receiving the 2011 Scrip Award for Best
Contract Research Organization (CRO).
"Winning this award for the second consecutive year is a
testament to the people of PPD," said David Simmons, chairman and CEO of
PPD. "In today's evolving health care model, CROs must be able to adapt to
clients' changing needs and proactively meet their challenges. PPD connects
talented people and innovative solutions to exceed the needs of our
biopharmaceutical industry clients, who are constantly seeking ways to increase
productivity and efficiency."
The Scrip Award for best technology recognized PPD®
3D, a virtual learning environment PPD created with ProtonMedia to provide
a scalable and sustainable global training model. PPD 3D improves how PPD
trains clinical research associates to monitor clinical trials, which is vital
for enhancing the quality of site management and clinical
monitoring for clients' research programs, and can contribute to faster
project startup.
"PPD were worthy winners of this award," said Mike Ward,
chief content officer for Datamonitor Healthcare and Scrip Intelligence.
"Their PPD 3D technology has improved the cost-effectiveness, speed and
quality of clinical trial training for the life sciences, and our judges were
impressed by the novel use of this type of technology in clinical research,
saying it has huge potential."
Posts
